Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients

INTRODUCTION: The current management of hyperphosphatemia with phosphate binders is associated with insufficient phosphorus control and a significant pill burden. Tenapanor, a first-in-class, phosphate absorption inhibitor, is expected to control phosphorus and decrease pill burden because of its sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Akizawa, Tadao, Sato, Yu, Ikejiri, Kazuaki, Kanda, Hironori, Fukagawa, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418975/
https://www.ncbi.nlm.nih.gov/pubmed/34514198
http://dx.doi.org/10.1016/j.ekir.2021.06.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418975/
https://www.ncbi.nlm.nih.gov/pubmed/34514198
http://dx.doi.org/10.1016/j.ekir.2021.06.030

Ejemplares similares